There are many people who suffer from migraines in their lives. When a migraine occurs, it is accompanied by a pulsating blood vessel from the temple to the eye, and the pain is unbearable because of the pins and needles. Usually, patients think that they can just put up with it, or they can just take some painkillers. Patients who suffer from migraine for a long time take a lot of medications, but the headache does not slow down, but they become more and more anxious and hesitant, and some even suffer from depression and have thoughts of light-heartedness. In the early stage of the disease, the headache symptoms are mild and can be tolerated by patients with strong will power. Alternatively, pain relief can be achieved through life rhythm adjustment, supplemented with pain-relieving and sedative drugs. There is no doubt that treatments, including medications, are an adjunctive therapy and cannot address the root cause of recurrent headaches. It is not uncommon for patients with intractable migraine to develop into cerebral infarction and intracranial hemorrhage, which seriously threaten the psychological and life health of patients. After years of clinical practice, the hospital, one of the hospitals that has launched systematic clinical research on migraine, has introduced manifest microvascular decompression. This technique works directly on the “pain points” where the nerves and blood vessels are entangled. Through microscopic guidance, the lesion is accurately found, the responsible blood vessel and nerve are separated, and the nerve is carefully protected, thus helping patients to cure migraine. Thousands of successful clinical cases have proven that microvascular decompression is the most effective migraine treatment procedure. The surgical incision is small, short, with few side effects and complications, and the success rate can reach over 98%.